FDA Reissues Notice on 3PL Definition in Drug Supply Chain Law, Delaying Comment Deadline

Comments are due Oct. 23 on a recently issued draft guidance document on the definition of trading partners, including third-party logistics providers (3PLs), under the Drug Supply Chain Security Act, the Food and Drug Administration said in an updated notice. The change is the result of the agency’s withdrawal of an Aug. 21 notice announcing the new draft guidance (see 1708210034). The updated notice is scheduled for publication Aug. 24, triggering a 60-day period for comments.